Tendinitis
is an inflammation of the thick cords, ligament, which attaches muscle to bone,
also known as tendonitis. An inflammation or swelling happens due to sudden
damage to the ligament, rheumatoid joint inflammation, redundant development of
diabetes, gout, Reiter's disorder or lupus. Tendinitis is one of the basic
sport injuries in the players, particularly golf, tennis, and others. Different
pharmacological & non-pharmacological medications are available for the
treatment of tendinitis. However, surgery is the last solution for tendinitis,
and is only recommended in case of severe injure to the tendon which cannot be
treated with pharmacological treatment options.
According
to study, “Tendinitis
Treatment Market Information: By Type (Achilles Tendinitis, Supraspinatus
Tendinitis, Tennis or Golfers Elbow, De Quervains Tenosynovitis), By Treatment
(Diagnosis, Therapy, Shock Wave Therapy or Surgery, Medical Devices, Devices),
By End User (Hospitals & Clinics, Medical Research Centers, Academic
Institutes) - Americas & Europe Forecast till 2023” the key
companies operating in the Americas & Europe tendinitis treatment market
are Abbott Laboratories, Merck & Co. Inc., Boehringer Ingelheim
Pharmaceuticals, Inc., GlaxoSmithKline plc., Pfizer Inc., Bayer, Teva
Pharmaceutical Industries, AstraZeneca.
Based
on type, Americas & Europe tendinitis treatment market is segmented into
Achilles Tendinitis, Tennis or Golfer's Elbow, Supraspinatus Tendinitis and De
Quervain's Tenosynovitis. Based on treatment, market is segmented into
diagnosis, shock wave therapy or surgery, therapy and medical devices and medical
devices (mechanical band, pre-cut strips, support tape and continuous rolls).
Diagnosis treatment is further sub-segmented into imaging tests (Magnetic
Resonance Imaging (MRI) scans and ultrasound), physical exam, and others. Therapy is further sub-segmented into
pharmacological and non-pharmacological therapy. Pharmacological therapy
includes corticosteroids injections, OTC drugs or pain relievers and
platelet-rich plasma (PRP) while non-pharmacological therapy includes rest
therapy, occupational therapy, heat & cold therapy and physical therapy.
Based on problem, market is segmented into golfer's elbow, pitcher's shoulder,
jumper's knee, swimmer's shoulder, tennis elbow, and others. In addition based
on end-user, market is segmented into hospitals & clinics, academic
institutes and medical research centers.
The
Americas & Europe tendinitis treatment market is driven by increase in
geriatric population, followed by rise in prevalence of sports injuries, rapid
adoption of new treatments, growth in healthcare infrastructure, innovative
product development, and increase in prevalence of patients suffering from
diabetes & rheumatoid. However, side effects of the treatment, lack of
physical activity and change in lifestyle may impact the market.
Based
on geography, American region is the major market for tendinitis treatment
owing to rise in prevalence of sport injuries & disease such as arthritis
and increase in demand for new treatment options for tendinitis in the region.
European region is expected to witness higher growth rate due to increase in
availability of funds for research and development (R&D) activities in
medical devices and rise in prevalence of diabetes & rheumatoid arthritis
over the forecast period. The market is expected to reach the approx value of
US $13,099.0 million by 2023 growing at a CAGR of 7.2% during the forecast
period.
For more information, click on the
link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91
9015378249
No comments:
Post a Comment